Надана інформація про лікарські засоби призначена виключно для ознайомлення і не є офертою, рекламою чи інструкцією щодо застосування. Продаж, доставка та призначення препаратів через сайт не здійснюються. З питань застосування препарату ви можете записатися на очний прийом або онлайн-консультацію до профільного спеціаліста нашої клініки.
GLUCOPHAGE 1000 mg (ITALY)
1 film-coated tablet of 1000 mg contains 1000 mg of metformin hydrochloride, which corresponds to 780 mg of metformin.
16у.е.
Glucophage 1000 mg
Composition
Active ingredient: metformin hydrochloride;
Each film-coated tablet of 1000 mg contains 1000 mg of metformin hydrochloride, equivalent to 780 mg of metformin;
Excipients: povidone K 30, magnesium stearate;
Film coating for 1000 mg tablets: Opadry Clear (hypromellose, macrogol 400, macrogol 8000).
Pharmacological group
Agents affecting the digestive system and metabolism. Antidiabetic drugs. Oral hypoglycemic agents, excluding insulins.
Indications
Type 2 diabetes mellitus when diet therapy and exercise regimen are ineffective, especially in overweight patients:
• As monotherapy or as part of combination therapy with other oral hypoglycemic agents or with insulin for the treatment of adults;
• As monotherapy or as part of combination therapy with insulin for the treatment of children from 10 years old and adolescents.
To reduce complications of diabetes mellitus in adult patients with type 2 diabetes and overweight as a first-line drug after ineffective diet therapy.
The package contains 60 tablets.
Composition
Active ingredient: metformin hydrochloride;
Each film-coated tablet of 1000 mg contains 1000 mg of metformin hydrochloride, equivalent to 780 mg of metformin;
Excipients: povidone K 30, magnesium stearate;
Film coating for 1000 mg tablets: Opadry Clear (hypromellose, macrogol 400, macrogol 8000).
Pharmacological group
Agents affecting the digestive system and metabolism. Antidiabetic drugs. Oral hypoglycemic agents, excluding insulins.
Indications
Type 2 diabetes mellitus when diet therapy and exercise regimen are ineffective, especially in overweight patients:
• As monotherapy or as part of combination therapy with other oral hypoglycemic agents or with insulin for the treatment of adults;
• As monotherapy or as part of combination therapy with insulin for the treatment of children from 10 years old and adolescents.
To reduce complications of diabetes mellitus in adult patients with type 2 diabetes and overweight as a first-line drug after ineffective diet therapy.
The package contains 60 tablets.
